Kallmann's syndrome:: A comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations

被引:83
|
作者
Salenave, Sylvie [1 ,2 ]
Chanson, Philippe [1 ,2 ,4 ]
Bry, Helene [1 ,2 ]
Pugeat, Michel [5 ]
Cabrol, Sylvie [6 ]
Carel, Jean Claude [2 ,7 ]
Murat, Arnaud [8 ]
Lecomte, Pierre [9 ]
Brailly, Sylvie [3 ,4 ]
Hardelin, Jean-Pierre [10 ]
Dode, Catherine [11 ]
Young, Jacques [1 ,2 ,4 ]
机构
[1] Hop Bicetre, Serv Endocrinol & Malad Reprod, AP HP, Le Kremlin Bicetre, France
[2] Ctr Reference Malad Endocriniennes Rares Croissan, F-94275 Le Kremlin Bicetre, France
[3] Univ Paris 11, Lab Genet Mol Pharmacogenet & Hormonol, F-94275 Le Kremlin Bicetre, France
[4] INSERM, U693, F-94275 Le Kremlin Bicetre, France
[5] Hop Neurol, Federat Endocrinol, F-69500 Bron, France
[6] Hop Trousseau, AP HP, Lab Explorat Fonctionnelles Endocriniennes, F-75012 Paris, France
[7] Hop Robert Debre, AP HP, Serv Endocrinol Pediat, F-75935 Paris, France
[8] CHU Nantes, Serv Endocrinol, F-44000 Nantes, France
[9] CHU Tours, Serv Endocrinol, F-37044 Tours, France
[10] Inst Pasteur, Unite Genet Deficits Sensoriels, F-75724 Paris, France
[11] Hop Cochin, AP HP, Lab Biochim & Genet Mol, F-75014 Paris, France
来源
关键词
D O I
10.1210/jc.2007-1168
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Kallmann's syndrome (KS) is a genetically heterogeneous disorder consisting of congenital hypogonadotropic hypogonadism (CHH) with anosmia or hyposmia. Objective: Our objective was to compare the reproductive phenotypes of men harboring KAL1 and FGFR1/KAL2 mutations. Design and Patients: We studied the endocrine features reflecting gonadotropic-testicular axis function in 39 men; 21 had mutations in KAL1 and 18 in FGFR1/KAL2, but none had additional mutations in PROK-2 or PROKR-2 genes. Results: Puberty failed to occur in the patients with KAL1 mutations, all of whom had complete CHH. Three patients with FGFR1/KAL2 mutations had normal puberty, were eugonadal, and had normal testosterone and gonadotropin levels. Cryptorchidism was more frequent ( 14 of 21 vs. 3 of 15; P < 00.1) and testicular volume (2.4 +/- 1.1 vs. 5.4 +/- 2.4 ml; P < 0.001) was smaller in CHH subjects with KAL1 mutations than in subjects with FGFR1/KAL2 mutations. The mean basal plasma FSH level (0.72 +/- 0.47 vs. 1.48 +/- 0.62 IU/liter; P < 0.05), serum inhibin B level (19.3 +/- 10.6 vs. 39.5 +/- 19.3 pg/ml; P < 0.005), basal LH plasma level (0.57 +/- 0.54 vs. 1.0 +/- 0.6 IU/liter; P < 0.01), and GnRH-stimulated LH plasma level (1.2 +/- 1.0 vs. 4.1 +/- 3.5 IU/liter; P < 0.01) were significantly lower in the subjects with KAL1 mutations. LH pulsatility was studied in 13 CHH subjects with KAL1 mutations and seven subjects with FGFR1/KAL2 mutations; LH secretion was nonpulsatile in all the subjects, but mean LH levels were lower in those with KAL1 mutations. Conclusion: KAL1 mutations result in a more severe reproductive phenotype than FGFR1/KAL2 mutations. The latter are associated with a broader spectrum of pubertal development and with less severe impairment of gonadotropin secretion.
引用
收藏
页码:758 / 763
页数:6
相关论文
共 50 条
  • [1] Kallmann syndrome with FGFR1 and KAL1 mutations detected during fetal life
    Julie Sarfati
    Claire Bouvattier
    Hélène Bry-Gauillard
    Alejandra Cartes
    Jérôme Bouligand
    Jacques Young
    Orphanet Journal of Rare Diseases, 10
  • [2] Kallmann syndrome with FGFR1 and KAL1 mutations detected during fetal life
    Sarfati, Julie
    Bouvattier, Claire
    Bry-Gauillard, Helene
    Cartes, Alejandra
    Bouligand, Jerome
    Young, Jacques
    ORPHANET JOURNAL OF RARE DISEASES, 2015, 10
  • [3] Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients
    Sato, N
    Katsumata, N
    Kagami, M
    Hasegawa, T
    Hori, N
    Kawakita, S
    Minowada, S
    Shimotsuka, A
    Shishiba, Y
    Yokozawa, M
    Yasuda, T
    Nagasaki, K
    Hasegawa, D
    Hasegawa, Y
    Tachibana, K
    Naiki, Y
    Horikawa, R
    Tanaka, T
    Ogata, T
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (03): : 1079 - 1088
  • [4] A novel KAL1 mutation identified in Kallmann syndrome
    Vicky Heath
    Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 (3): : 124 - 124
  • [5] A novel mutation of the KAL1 gene in Kallmann syndrome
    Izumi, Y
    Tatsumi, K
    Okamoto, S
    Hosokawa, A
    Ueno, S
    Fukui, H
    Amino, N
    ENDOCRINE JOURNAL, 1999, 46 (05) : 651 - 658
  • [6] Identification of three novel mutations in the KAL1 gene in patients with Kallmann syndrome
    Söderlund, D
    Canto, P
    Méndez, JP
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (06): : 2589 - 2592
  • [7] Genetic Analysis in Patients With Kallmann Syndrome: Coexistence of Mutations in Prokineticin Receptor 2 and KAL1
    Canto, P.
    Munguia, P.
    Soderlund, D.
    Castro, J. J.
    Mendez, J. P.
    JOURNAL OF ANDROLOGY, 2009, 30 (01): : 41 - 45
  • [8] A fertile male patient with Kallmann syndrome and two missense mutations in the KAL1 gene
    Zhang, Shilin
    Wang, Tao
    Yang, Jun
    Liu, Zhuo
    Wang, Shaogang
    Liu, Jihong
    FERTILITY AND STERILITY, 2011, 95 (05) : 1789.e3 - 1789.e6
  • [9] Analysis of the KAL1 gene in 19 Japanese patients with Kallmann syndrome
    Izumi, Y
    Tatsumi, K
    Okamoto, S
    Ogawa, T
    Hosokawa, A
    Matsuo, T
    Kato, Y
    Fukui, H
    Amino, N
    ENDOCRINE JOURNAL, 2001, 48 (02) : 143 - 149
  • [10] A novel interstitial deletion of KAL1 in a Japanese family with Kallmann syndrome
    Nagata, K
    Yamamoto, T
    Chikumi, H
    Ikeda, T
    Yamamoto, H
    Hashimoto, K
    Yoneda, K
    Nanba, E
    Ninomiya, H
    Ishitobi, K
    JOURNAL OF HUMAN GENETICS, 2000, 45 (04) : 237 - 240